The effect of the histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice

Gene Therapy

Volumn 14, Issue 17, 2007, Pages 1261-1269

  Mesojednik, S ^a   Pavlin, D ^b   Sersa, G ^a   Coer, A ^b   Kranjc, S ^a   Grosel, A ^a   Tevz, G ^a   Cemazar, M ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ENHANCED GREEN FLUORESCENT PROTEIN; LUCIFERASE; PARAFFIN; PLASMID DNA; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER TISSUE; CARCINOMA; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; ELECTROPORATION; FEMALE; FIBROSARCOMA; GENE TARGETING; GENETIC TRANSFECTION; HISTOPATHOLOGY; IN VIVO STUDY; MELANOMA; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULSED ELECTRIC FIELD; SOLID TUMOR; SPINDLE CELL; TISSUE SECTION;

ANIMALS; CARCINOMA; CELL COUNT; CELL LINE, TUMOR; CELL SIZE; COLLAGEN; DNA; ELECTROPORATION; FIBROSARCOMA; GENE EXPRESSION; GENE THERAPY; GREEN FLUORESCENT PROTEINS; INJECTIONS; LUCIFERASES; MELANOMA; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED STRAINS; MICROSCOPY, FLUORESCENCE; NECROSIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTEOGLYCANS; RANDOM ALLOCATION; SARCOMA; TIME FACTORS; TRANSFECTION;

MUS;

EID: 34548136132     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302989     Document Type: Article

References (41)

1. Nishikawa M, Huang L. Non-viral vectors in the new millennium: Delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
2. Cemazar M, Golzio M, Sersa G, Rols MR, Teissie J. Electrically-assisted nucleic acids delivery to tissues in vivo: Where do we stand? Curr Pharm Des 2006; 12: 3817-3825.
3. Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther 2006; 17: 890-897.
4. Cemazar M, Grosel A, Glavac D, Kotnik V, Skobrne M, Kranjc S et al. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status. DNA Cell Biol 2003; 22: 765-775.
5. Haupt S, Haupt Y. Manipulation of the tumor suppressor p53 for potentiating cancer therapy. Semin Cancer Biol 2004; 14: 244-252.
6. Bettan M, Ivanov MA, Mir LM, Boissiere F, Delaere P, Scherman D. Efficient DNA electrotransfer into tumors. Bioelectrochemistry 2000; 52: 83-90.
7. Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A et al. Effective gene transfer to solid tumors using different non-viral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector. Cancer Gene Ther 2002; 9: 399-406.
8. Heller L, Jaroszeski MJ, Coppola D, Pottinger C, Gilbert R, Heller R. Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Therapy 2000; 7: 826-829.
9. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16: 168-171.
10. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporation-enhanced gene delivery in mammary tumors. Gene Therapy 2000; 7: 541-547.
11. Cichon T, Jamrozy L, Glogowska J, Missol-Kolka E, Szala S. Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread. Cancer Gene Ther 2002; 9: 771-777.
12. Collins CG, Tangney M, Larkin JO, Casey G, Whelan MC, Cashman J et al. Local gene therapy of solid tumors with GM-CSF and B7-1 eradicates both treated and distal tumors. Cancer Gene Ther 2006; 13: 1061-1071.
13. Grosel A, Sersa G, Kranjc S, Cemazar M. Electrogene therapy with p53 of murine sarcomas alone or combined with electro-chemotherapy using cisplatin. DNA Cell Biol 2006; 25: 674-683.
14. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5: 668-675.
15. Tamura T, Nishi T, Goto T, Takeshima H, Ushio Y, Sakata T. Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth. Anticancer Res 2003; 23: 1173-1179.
16. Gehl J. Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
17. Li S. Electroporation gene therapy: New developments in vivo and in vitro. Curr Gene Ther 2004; 4: 309-316.
18. Somiari S, Glasspool-Malone J, Drabick JJ, Gilbert RA, Heller R, Jaroszeski MJ et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2000; 2: 178-187.
19. Smrekar B, Wightman L, Wolschek MF, Lichtenberger C, Ruzicka R, Ogris M et al. Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Therapy 2003; 10: 1079-1088.
20. Zaharoff DA, Barr RC, Li CY, Yuan F. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery. Gene Therapy 2002; 9: 1286-1290.
21. Canatella PJ, Black MM, Bonnichsen DM, McKenna C, Prausnitz MR. Tissue electroporation: Quantification and analysis of heterogeneous transport in multicellular environments. Biophys J 2004, 86: 3260-3268.
22. Baumgartner G. The impact of extracellular matrix on chemoresistance of solid tumors - experimental and clinical results of hyalurunidase as additive to cytostatic chemotherapy. Cancer Lett 1998; 131: 1-2.
23. Davis AJ, Tannock IF. Tumor physiology and resistance to chemotherapy: repopulation and drug penetration. Cancer Treat Res 2002; 112 1-26.
24. Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 2002; 8: 878-884.
25. Grantab R, Sivananthan S, Tannock IF. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 2006; 66: 1033-1039.
26. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006; 6: 583-592.
27. Netti PA, Hamberg LM, Babich JW, Kierstead D, Graham W, Hunter GJ et al. Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules. Proc Natl Acad Sci USA 1999; 96 3137-3142.
28. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000; 60: 2497-2503.
29. Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, Tomaso E et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs subcutaneous tumors. Proc Natl Acad Sci USA 2001; 98: 4628-4633.
30. Alexandrakis G, Brown EB, Tong RT, McKee TD, Campbell RB, Boucher Y et al. Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors. Nat Med 2004; 10: 203-207.
31. Valic B, Golzio M, Pavlin M, Schatz A, Faurie C, Gabriel B et al. Effect of electric field induced transmembrane potential on spheroidal cells: Theory and experiment. Eur Biophys J 2003; 32: 519-528.
32. Susil R, Semrov D, Miklavcic D. Electric field-induced transmembrane potential depends on cell density and organization. Electro- and Magnetobiology 1998; 17: 391-399.
33. Cemazar M, Pavlin D, Kranjc S, Grosel A, Mesojednik S, Sersa G. Sequence and time dependence of transfection efficiency of electrically-assisted gene delivery to tumors in mice. Curr Drug Deliv 2006; 3: 77-81.
34. Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 1999; 96: 4262-4267.
35. Gimsa J, Wachner D. Analytical description of the transmembrane voltage induced on arbitrarily oriented ellipsoidal and cylindrical cells. Biophys J 2001; 81: 1888-1896.
36. Sixou S, Teissie J. Specific electropermeabilization of leucocytes in a blood sample and application to large volumes of cells. Biochim Biophys Acta 1990; 1028: 154-160.
37. Andre FM, Cournil-Henrionnet C, Vernerey D, Opolon P, Mir LM. Variability of naked DNA expression after direct local injection: The influence of the injection speed. Gene Therapy 2006; 13: 1619-1627.
38. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100 57-70.
39. Golzio M, Rols MP, Teissie J. In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expression. Methods 2004; 33: 126-135.
40. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation-enhanced non-viral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006; 6: 243-273.
41. Cemazar M, Wilson I, Dachs GU, Tozer GM, Sersa G. Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy - spatial and time dependent distribution. BMC Cancer 2004; 4: 81.